3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
7
Gastrointestinal
6
Sarcoma
2
Plasma cell
1
Dermatologic
1
Conditions
Sarcoma
210
Bone Neoplasms
58
Neoplasms
39
Breast Neoplasms
39
Osteosarcoma
37
Lymphoma
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Gastrointestinal Stromal Tumors
31
Dendritic Cell Sarcoma, Interdigitating
31
Hodgkin Disease
29
Lymphoma, Non-Hodgkin
27
Leukemia
27
Burkitt Lymphoma
25
Melanoma
24
Brain Neoplasms
24
Multiple Myeloma
23
Leukemia, Myeloid, Acute
23
Sarcoma, Ewing
22
Recurrence
21
Lymphoma, Mantle-Cell
21
Lymphoma, Large B-Cell, Diffuse
21
Glioblastoma
21
Neuroblastoma
20
Lymphoma, Follicular
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Lymphoma, Large-Cell, Immunoblastic
18
Gliosarcoma
18
Sarcoma, Kaposi
17
Prostatic Neoplasms
17
Pancreatic Neoplasms
17
Interventions
regorafenib
1
Transurethral Resection of Bladder
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Pathologic Complete Response
×
Sarcoma
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled
NCT05684874
2023-10-30
SarQuantIRM
Centre Leon Berard
Phase NA
Unknown
25 enrolled